# COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

> **NCT02744677** · NA · RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 108 (estimated)

## Conditions studied

- Complex Congenital Heart Defect
- Dysfunctional RVOT Conduit
- Pulmonary Valve Insufficiency
- Pulmonary Valve Degeneration

## Interventions

- **DEVICE:** SAPIEN 3/SAPIEN 3 Ultra RESILIA THV
- **DEVICE:** SAPIEN 3 THV
- **DEVICE:** SAPIEN 3 Ultra RESILIA THV

## Key facts

- **NCT ID:** NCT02744677
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-07-05
- **Primary completion:** 2026-12
- **Final completion:** 2031-06
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02744677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02744677, "COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02744677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*